Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-10

Clinical Trial Update: Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vaginal progesterone 400 mg vs 200 mg for prevention of preterm labor in twin pregnancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • progesterone vaginal 200 mg (progesterone)
  • progesterone vaginal 400 mg (progesterone)

Snippet

Sponsor: Ain Shams University | Conditions: Twin Pregnancy With Antenatal Problem | Phase 4 | Status: COMPLETED